Feb. 26: Who’s bringing the popcorn? Executives from seven Massive Pharma corporations will line up for questioning from the Senate Finance Committee in a listening to dubbed “Drug Pricing in America: A Prescription for Change, Half II.” Committee Chairman Chuck Grassley (R-Iowa) began the inquiry into drug costs final month. Grassley has supported efforts to crack down on producer pay-to-delay techniques that stall generics from getting into the market, in addition to laws to expedite generic medicine and biosimilars to market, which faces opposition from drug corporations.
Feb. 27: The Senate Commerce, Science and Transportation Committee is scheduled to look at what steps Congress can take to enhance knowledge safety. “In an age of speedy innovation in expertise, shoppers want transparency in how their knowledge is collected and used,” committee Chairman Roger Wicker (R-Miss.) mentioned in an announcement asserting the listening to.
Feb. 27: King of Prussia, Pa.-based Common Well being Providers might ship optimistic information in its earnings name. Analysts challenge This autumn income to be up three.four% from the prior-year interval. Throughout a third-quarter earnings name in October, UHS Chief Monetary Officer Steve Filton softened the group’s stance on elevating income by 5% in 2018. “We proceed to work in a very centered and disciplined approach on bettering that behavioral same-store income progress dynamic,” he mentioned. “However I feel we additionally acknowledge that we have created this 5% goal and now disenchanted a few instances each internally and externally.”